We investigated the effect of ARB on PSMA expression over a 3-week period in PSMA-low human prostate cancer cell line 22Rv1 and PSMA-high human prostate cancer cell lines C4-2 and LNCaP. The gene discussed is FOLH1; the disease is prostate carcinoma.